CCL7 and kidney disorder: Due to the multiple redundancy system among chemokines and their receptors, further experimental and clinical studies should be interesting to focus on direct anti-CCL7 mechanisms as a promising therapeutic approach to attenuating the development of cardiovascular disease DM, and kidney disease.